Li Deng-Ke, Chen Jing, Ge Zhen-Zhen, Sun Zhen-Xiao
School of Chinese Materia Medica, Beijing University of Chinese Medicine, 6 Wang Jing Zhong Huan Nan Lu, Chaoyang District, Beijing 100102, China.
Evid Based Complement Alternat Med. 2017;2017:9456785. doi: 10.1155/2017/9456785. Epub 2017 May 24.
The objective of this study is to investigate the relationship between the hepatotoxicity induced by Polygoni Multiflori Radix (PMR, root of Thunb., He Shou Wu) and the activity of CYP1A2 or CYP2E1 in the rat liver. Levels of rat serum transaminases ALT and AST were not altered but the activity of CYP1A2 or CYP2E1 in the rat liver was significantly inhibited after oral administration of aqueous extract of PMR under the experimental dosage. However, levels of ALT and AST were significantly increased and the activity of CYP1A2 or CYP2E1 was significantly decreased after injection of specific inhibitor for CYP1A2 or CYP2E1 combined with oral administration of aqueous extract of PMR, especially under the repeated treatment over interval times. Liver histopathological observation showed that a moderate liver injury occurred in rats receiving PMR treatment with the activity of CYP1A2 or CYP2E1 inhibited, but there was no significant liver damage in rats receiving PMR treatment or CYP inhibitor alone. These suggested that low level activity of CYP1A2 or CYP2E1 from genetic polymorphism among people might be one of the important reasons for the hepatotoxicity induced by PMR in clinical practice.
本研究的目的是探讨何首乌(PMR,蓼科植物何首乌的根)诱导的肝毒性与大鼠肝脏中CYP1A2或CYP2E1活性之间的关系。在实验剂量下口服何首乌水提取物后,大鼠血清转氨酶ALT和AST水平未改变,但大鼠肝脏中CYP1A2或CYP2E1的活性受到显著抑制。然而,在注射CYP1A2或CYP2E1特异性抑制剂并联合口服何首乌水提取物后,尤其是在间隔时间重复治疗的情况下,ALT和AST水平显著升高,CYP1A2或CYP2E1的活性显著降低。肝脏组织病理学观察表明,在CYP1A2或CYP2E1活性受到抑制的情况下,接受何首乌治疗的大鼠出现中度肝损伤,但单独接受何首乌治疗或CYP抑制剂治疗的大鼠没有明显的肝损伤。这些结果表明,人群中因基因多态性导致的CYP1A2或CYP2E1低水平活性可能是临床实践中何首乌诱导肝毒性的重要原因之一。